ChemComm
Communication
Cy2SI protecting group from the purified oligos with [NH4OH], 7 M
NH3 in MeOH, or AMA (1 : 1 mixture of [NH4OH] and 40% aq.
methylamine) at 55 1C was unfortunately met with little success.
In summary, we have developed a new directing/protecting
group that provided an effective means to access 6-aminopurine-
20-deoxynucleosides with a high regioselectivity for the desired
b-N9 product over the b-N7 product. This Cy2SI protecting group
also provided this advantage to alkylation reactions in which the
N9 product was formed in a significant excess over the undesired
N7 product. Structural analysis using X-ray crystallography con-
firmed that portions of both cyclohexyl groups are positioned to
sterically block access to the N7 nitrogen, thereby promoting
reaction at the N9 position instead. This advantage became
especially apparent in the synthesis of valuable C3 substituted
purines in which the desired products could be easily isolated in
high yields.14 Since it has been previously shown that running
purine glycosylation reactions in less polar solvents can reduce
the number of a-nucleosides produced during the reaction,15
further development of directing/protecting groups is ongoing in
our laboratory.
Scheme 2 Selective removal of toluoyl and Cy2SI protecting groups.
We gratefully acknowledge funding from the NSF (MCB
0958515) for this research. We would also like to thank
Dr Han Yueh and Ms Alena Carlson for their generous donation
of synthetic intermediates.
Scheme 3 Synthesis of phosphoramidite 14.
also be noted that although both the N9 and N7 regioisomers
were detected in the crude 1H NMR spectra for the corres-
ponding heterocycles containing Ndmf protection (Entries 16
and 18), only the N7 product could be isolated via column
chromatography.
Notes and references
1 L. J. Wilson, M. W. Hager, Y. A. El-Katan and D. C. Liotta, Synthesis,
1995, 1465–1479.
2 M. Hoffer, Chem. Ber., 1960, 93, 2777–2781.
3 V. Rolland, M. Kotera and J. Lhomme, Synth. Commun., 1997, 27,
3505–3511.
4 Z. Kazimierczuk, H. B. Cottam, G. R. Revankar and R. K. Robins,
J. Am. Chem. Soc., 1984, 106, 6379–6382.
5 R. J. Irani and J. Santalucia, Nucleosides Nucleotides Nucleic Acids,
2002, 21, 737–751.
6 M. Zhong, I. Nowak, J. F. Cannon and M. J. Robins, J. Org. Chem.,
2006, 71, 4216–4221.
7 M. Zhong, I. Nowak and M. J. Robins, J. Org. Chem., 2006, 71,
7773–7779.
8 J. W. Arico, A. K. Calhoun, K. J. Salandria and L. W. McLaughlin,
Org. Lett., 2010, 12, 120–122.
9 C. G. Overberg, H. Biletch, P. T. Huang and H. M. Blatter, J. Org.
Chem., 1955, 20, 1717–1720.
The hydrolytic stability of the Cy2SI protecting group also
presented a synthetic advantage over other protecting groups.
After glycosylation, the toluoyl esters of the newly formed
nucleoside, for example 8, could be selectively removed using
7 M ammonia in methanol at ambient temperature to produce
compound 9 in 92% yield without affecting the Cy2SI group
(Scheme 2). Further reaction of compound 9 in concentrated
aqueous ammonium hydroxide at 55 1C completely removed
the imide protecting group and produced the free nucleoside
10 in 84% yield.
Encouraged by those results, we decided to test the feasi-
bility of using Cy2SI as a protecting group during DNA oligo- 10 K. Okumura, T. Oine, Y. Yamada, M. Tomie, T. Adachi, T. Nagura,
M. Kawazu, T. Mizoguchi and I. Inoue, J. Org. Chem., 1971, 36,
1573–1579.
11 (a) T. Fujii and T. Itaya, Heterocycles, 1998, 48, 1673–1724;
nucleotide synthesis. The synthesis of phosphoramidite 14
proceeded using well established procedures starting from
compound 11 (Scheme 3). After removal of the toluoyl esters
in 11 using 7 M NH3 in MeOH, the free 50-OH in 12 was
selectively protected using 4,40-dimethoxytrityl chloride in
(b) E. Enkvist, G. Raidaru, A. Uri, R. Patel, C. Redick, J. L. Boyer,
J. Subbi and I. Tammiste, Nucleosides Nucleotides Nucleic Acids, 2006,
25, 141–157; (c) Q. Zhang, G. Cheng, Y.-Z. Huang, G.-R. Qu, H.-Y. Niu
and H.-M. Guo, Tetrahedron, 2012, 68, 7822–7826.
pyridine to afford compound 13 in 84% yield. Compound 13 12 (a) P. E. Nielsen, Acc. Chem. Res., 1999, 32, 624–630; (b) P. E. Nielsen,
Chem. Biodiversity, 2010, 7, 786–804; (c) E. Uhlmann, A. Peyman,
G. Breipohl and D. W. Will, Angew. Chem., Int. Ed., 1998, 37,
2796–2823.
was then transformed into phosphoramidite 14 using 2-cyanoethyl
N,N,N0,N0-tetraisopropylphosphordiamidite and tetrazole in DCM
in 63% yield. With this phosphoramidite in hand, we were able 13 (a) M. K. Schlegel and E. Meggers, J. Org. Chem., 2009, 74,
4615–4618; (b) M. K. Schlegel, J. Hu¨tter, M. Eriksson, B. Lepenies
and P. H. Seeberger, ChemBioChem, 2011, 12, 2791–2800.
14 K. J. Salandria, J. W. Arico, A. K. Calhoun and L. W. McLaughlin,
to successfully synthesize two 15-mer oligonucleotides which
incorporated one or two modified nucleotides containing the Cy2SI
protecting group. However, after cleavage/deprotection and purifi-
cation over a C18 Sep-Pak column13 we observed exclusively the
oligonucleotide product which still contained full Cy2SI protection
in both oligos (see ESI†). Further attempts at the removal of the
J. Am. Chem. Soc., 2011, 133, 1766–1768.
15 (a) G. Ritzmann, R. S. Klein, D. H. Hollenberg and J. J. Fox,
Carbohydr. Res., 1975, 39, 227–236; (b) H. G. Howell,
P. R. Brodfuehrer, S. P. Brundlage, D. A. Benigni and C. Sapino,
J. Org. Chem., 1988, 53, 85–88.
c
2938 Chem. Commun., 2013, 49, 2936--2938
This journal is The Royal Society of Chemistry 2013